{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:32:50Z","timestamp":1793111570645,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s11695-026-08913-w","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:05:57Z","timestamp":1788307557000},"page":"5721-5730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Excess-weight Metrics Misrepresent Weight Loss and All Weight Metrics Poorly Predict Early Glycemic Outcome After Metabolic and Bariatric Surgery"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6106-9894","authenticated-orcid":false,"given":"Dong Wook","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2707-1768","authenticated-orcid":false,"given":"Eric","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Nimeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagney","family":"Cristancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyungoo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Apovian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"3","key":"8913_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.soard.2015.02.003","volume":"11","author":"SA Brethauer","year":"2015","unstructured":"Brethauer SA, Kim J, el Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11(3):489\u2013506. https:\/\/doi.org\/10.1016\/j.soard.2015.02.003. PMID: 26093765.","journal-title":"Surg Obes Relat Dis"},{"issue":"12","key":"8913_CR2","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s11695-012-0736-7","volume":"22","author":"A van de Laar","year":"2012","unstructured":"van de Laar A. Bariatric Outcomes Longitudinal Database (BOLD) suggests excess weight loss and excess BMI loss to be inappropriate outcome measures, demonstrating better alternatives. Obes Surg. 2012;22(12):1843\u20137. https:\/\/doi.org\/10.1007\/s11695-012-0736-7. PMID: 22923311.","journal-title":"Obes Surg"},{"issue":"6","key":"8913_CR3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2337\/dc16-0236","volume":"39","author":"F Rubino","year":"2016","unstructured":"Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39(6):861\u201377. https:\/\/doi.org\/10.2337\/dc16-0236. PMID: 27222544.","journal-title":"Diabetes Care"},{"issue":"10","key":"8913_CR4","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.soard.2022.06.296","volume":"18","author":"S Shahwan","year":"2022","unstructured":"Shahwan S, Oochit K, Campbell E, Kourounis G. Reporting of weight loss outcomes in bariatric surgery following introduction of 2015 ASMBS guidelines. Surg Obes Relat Dis. 2022;18(10):1195\u20138. https:\/\/doi.org\/10.1016\/j.soard.2022.06.296. PMID: 35927167.","journal-title":"Surg Obes Relat Dis"},{"issue":"3","key":"8913_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.4158\/EP161688.PS","volume":"23","author":"JI Mechanick","year":"2017","unstructured":"Mechanick JI, Hurley DL, Garvey WT. Adiposity-based chronic disease as a new diagnostic term: the American Association of Clinical Endocrinologists and American College of Endocrinology position statement. Endocr Pract. 2017;23(3):372\u20138. https:\/\/doi.org\/10.4158\/EP161688.PS. PMID: 27967229.","journal-title":"Endocr Pract"},{"issue":"3","key":"8913_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13(3):221\u201362. https:\/\/doi.org\/10.1016\/S2213-8587(24)00316-4. PMID: 39824205.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"8913_CR7","volume-title":"Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Participant Use Data File (PUF)","author":"American College of Surgeons, American Society for Metabolic and Bariatric Surgery","year":"2023","unstructured":"American College of Surgeons, American Society for Metabolic and Bariatric Surgery. Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Participant Use Data File (PUF). Chicago, IL: American College of Surgeons; 2023."},{"key":"8913_CR8","first-page":"650","volume":"8","author":"BJ Devine","year":"1974","unstructured":"Devine BJ. Gentamicin therapy. Drug Intell Clin Pharm. 1974;8:650\u20135.","journal-title":"Drug Intell Clin Pharm"},{"issue":"6","key":"8913_CR9","first-page":"1016","volume":"40","author":"JD Robinson","year":"1983","unstructured":"Robinson JD, Lupkiewicz SM, Palenik L, Lopez LM, Ariet M. Determination of ideal body weight for drug dosage calculations. Am J Hosp Pharm. 1983;40(6):1016\u20139. PMID: 6869387.","journal-title":"Am J Hosp Pharm"},{"issue":"Suppl 1","key":"8913_CR10","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.2337\/dc24-S006","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes\u20142024. Diabetes Care. 2024;47(Suppl 1):S111\u201325. https:\/\/doi.org\/10.2337\/dc24-S006","journal-title":"Diabetes Care"},{"issue":"11","key":"8913_CR11","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.2337\/dc09-9036","volume":"32","author":"JB Buse","year":"2009","unstructured":"Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133\u20135. https:\/\/doi.org\/10.2337\/dc09-9036. PMID: 19875608.","journal-title":"Diabetes Care"},{"issue":"3","key":"8913_CR12","doi-asserted-by":"publisher","first-page":"e14669","DOI":"10.1111\/dme.14669","volume":"38","author":"MC Riddle","year":"2021","unstructured":"Riddle MC, Cefalu WT, Evans PH, et al. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabet Med. 2021;38(3):e14669. https:\/\/doi.org\/10.1111\/dme.14669","journal-title":"Diabet Med"},{"issue":"3","key":"8913_CR13","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345. PMID: 3203132.","journal-title":"Biometrics"},{"issue":"1","key":"8913_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S2213-8587(13)70070-6","volume":"2","author":"CD Still","year":"2014","unstructured":"Still CD, Wood GC, Benotti P, et al. Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study. Lancet Diabetes Endocrinol. 2014;2(1):38\u201345. https:\/\/doi.org\/10.1016\/S2213-8587(13)70070-6. PMID: 24579062.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"8913_CR15","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1007\/s00125-017-4371-7","volume":"60","author":"J Aron-Wisnewsky","year":"2017","unstructured":"Aron-Wisnewsky J, Sokolovska N, Liu Y, et al. The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass. Diabetologia. 2017;60(10):1892\u2013902. https:\/\/doi.org\/10.1007\/s00125-017-4371-7. PMID: 28733906.","journal-title":"Diabetologia"},{"issue":"17","key":"8913_CR16","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa1200111","volume":"366","author":"G Mingrone","year":"2012","unstructured":"Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577\u201385. https:\/\/doi.org\/10.1056\/NEJMoa1200111. PMID: 22449317.","journal-title":"N Engl J Med"},{"issue":"3","key":"8913_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/SLA.0000000000000863","volume":"261","author":"S Panunzi","year":"2015","unstructured":"Panunzi S, De Gaetano A, Carnicelli A, Mingrone G. Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis. Ann Surg. 2015;261(3):459\u201367. https:\/\/doi.org\/10.1097\/SLA.0000000000000863. PMID: 25361217.","journal-title":"Ann Surg"},{"issue":"6","key":"8913_CR18","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2337\/dc16-0145","volume":"39","author":"RL Batterham","year":"2016","unstructured":"Batterham RL, Cummings DE. Mechanisms of diabetes improvement following bariatric\/metabolic surgery. Diabetes Care. 2016;39(6):893\u2013901. https:\/\/doi.org\/10.2337\/dc16-0145. PMID: 27222547.","journal-title":"Diabetes Care"},{"issue":"9","key":"8913_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","volume":"7","author":"IJ Neeland","year":"2019","unstructured":"Neeland IJ, Ross R, Despr\u00e9s JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715\u201325. https:\/\/doi.org\/10.1016\/S2213-8587(19)30084-1. PMID: 31301983.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"8913_CR20","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/j.soard.2019.04.004","volume":"15","author":"K Heshmati","year":"2019","unstructured":"Heshmati K, Harris DA, Aliakbarian H, Tavakkoli A, Sheu EG. Comparison of early type 2 diabetes improvement after gastric bypass and sleeve gastrectomy: medication cessation at discharge predicts 1-year outcomes. Surg Obes Relat Dis. 2019;15(12):2025\u201332. https:\/\/doi.org\/10.1016\/j.soard.2019.04.004. PMID: 31711946.","journal-title":"Surg Obes Relat Dis"},{"issue":"11","key":"8913_CR21","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989\u20131002. https:\/\/doi.org\/10.1056\/NEJMoa2032183. PMID: 33567185.","journal-title":"N Engl J Med"},{"issue":"3","key":"8913_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2206038. PMID: 35658024.","journal-title":"N Engl J Med"},{"key":"8913_CR23","volume-title":"Guidance for Industry: Developing Products for Weight Management (Draft Guidance)","author":"US Food and Drug Administration","year":"2007","unstructured":"US Food and Drug Administration. Guidance for Industry: Developing Products for Weight Management (Draft Guidance). Rockville, MD: US Food and Drug Administration; 2007."},{"issue":"24","key":"8913_CR24","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221\u201332. https:\/\/doi.org\/10.1056\/NEJMoa2307563. PMID: 37952131.","journal-title":"N Engl J Med"},{"issue":"2","key":"8913_CR25","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11606-013-2595-x","volume":"29","author":"MS Radin","year":"2014","unstructured":"Radin MS. Pitfalls in hemoglobin A1c measurement: when results may be misleading. J Gen Intern Med. 2014;29(2):388\u201394. https:\/\/doi.org\/10.1007\/s11606-013-2595-x. PMID: 24002631.","journal-title":"J Gen Intern Med"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08913-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-026-08913-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08913-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:36:12Z","timestamp":1793108172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-026-08913-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["8913"],"URL":"https:\/\/doi.org\/10.1007\/s11695-026-08913-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-10311858\/v1","asserted-by":"object"}]},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"10 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This retrospective study analyzed a fully de-identified public-use dataset and was determined not to constitute human subjects research. For this type of study formal consent is not required.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used a fully de-identified public-use dataset, and informed consent was not applicable.","order":2,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D.W.K. reports research support from Takeda Pharma Inc., Currax Pharma Inc., and Hanmi Pharma. E.G.S. reports research support from the National Institutes of Health (NIDDK R01), the Novo Nordisk Foundation, Medtronic Inc., and the Massachusetts Life Sciences Center, personal fees from Post and Schell PC, Elliot Hospital, and Cine-Med Inc., and holds two issued and two pending patents for novel treatments for diabetes, obesity, and hypoglycemia. C.M.A. has received research funding from PCORI and GI Dynamics Inc. and participated on advisory boards for Aardvark Therapeutics Inc., AbbVie Inc., Altimmune Inc., Arrowhead Pharmaceuticals Inc., BioAge, Biolinq Incorporated, Caribou Biosciences Inc., CinFina Pharma Inc., Covidien LP, Cowen and Company LLC, Currax Pharma Inc, EPG Communication Holdings Ltd., Form Health Inc., Fractyl Health Inc., Keros Therapeutics Inc., L-Nutra Inc., Lilly USA LLC, Mediflix Inc., Metsera Inc., NeuroBo Pharmaceuticals Inc., Neurocrine Biosciences Inc., NodThera Limited, Nutrisystem, OptumRx Inc., Pain Script Corporation, Palatin Technologies Inc., Redesign Health Inc., ReShape Lifesciences Inc., Riverview School, Roman Health Ventures Inc., Scholar Rock Inc., Terns Inc., Verily Life Sciences LLC, Veru Inc., Vida Health Inc., Viking Therapeutics Inc., Wave Life Sciences, Wondr Health, Xeno Biosciences, and Zyversa Therapeutics Inc. A.A.N. is a speaker for Medtronic and an advisory board member for Ethicon. M.E.M., C.C.C., K.S., and H.S. declare no conflicts of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}